company background image
7DC logo

Diaceutics DB:7DC Stock Report

Last Price

€1.14

Market Cap

€100.2m

7D

-0.9%

1Y

0%

Updated

18 Mar, 2024

Data

Company Financials +

7DC Stock Overview

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

7DC fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Diaceutics PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Diaceutics
Historical stock prices
Current Share PriceUK£1.14
52 Week HighUK£1.27
52 Week LowUK£0.91
Beta0.42
1 Month Change1.79%
3 Month Change9.62%
1 Year Change0%
3 Year Change-14.29%
5 Year Changen/a
Change since IPO-1.26%

Recent News & Updates

Recent updates

Shareholder Returns

7DCDE Life SciencesDE Market
7D-0.9%1.4%0.8%
1Y0%-6.7%6.2%

Return vs Industry: 7DC exceeded the German Life Sciences industry which returned -6.7% over the past year.

Return vs Market: 7DC underperformed the German Market which returned 6.2% over the past year.

Price Volatility

Is 7DC's price volatile compared to industry and market?
7DC volatility
7DC Average Weekly Movement6.7%
Life Sciences Industry Average Movement6.4%
Market Average Movement4.7%
10% most volatile stocks in DE Market10.3%
10% least volatile stocks in DE Market2.5%

Stable Share Price: 7DC has not had significant price volatility in the past 3 months.

Volatility Over Time: 7DC's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005151Ryan Keelinghttps://www.diaceutics.com

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network.

Diaceutics PLC Fundamentals Summary

How do Diaceutics's earnings and revenue compare to its market cap?
7DC fundamental statistics
Market cap€100.18m
Earnings (TTM)€7.01k
Revenue (TTM)€25.59m

Over9,999x

P/E Ratio

3.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7DC income statement (TTM)
RevenueUK£21.90m
Cost of RevenueUK£2.77m
Gross ProfitUK£19.13m
Other ExpensesUK£19.13m
EarningsUK£6.00k

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

May 21, 2024

Earnings per share (EPS)0.000071
Gross Margin87.37%
Net Profit Margin0.027%
Debt/Equity Ratio0%

How did 7DC perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.